
|Articles|September 1, 2003
TACROLIMUS SAFE, EFFECTIVE
Fujisawa Inc, released data recently that supports the safety and efficacy of Protopic (tacrolimus ointment) 0.03 percent concentration in children with mild to moderate atopic dermatitis.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Envudeucitinib Shows Durable Skin Clearance in Phase 3 Psoriasis Extension
2
The Emerging Role of Oral Peptide Therapeutics in Psoriasis and Beyond
3
Social Media Mythbusters: Hydrocolloid Pimple Patches
4
Allergan Aesthetics Refreshes APP Loyalty Program for Aesthetic Practices
5










